ID   GLCNE_RAT               Reviewed;         722 AA.
AC   O35826;
DT   15-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   24-JUL-2024, entry version 153.
DE   RecName: Full=Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase {ECO:0000305|PubMed:9305888};
DE   AltName: Full=UDP-GlcNAc-2-epimerase/ManAc kinase;
DE   Includes:
DE     RecName: Full=UDP-N-acetylglucosamine 2-epimerase (hydrolyzing) {ECO:0000305|PubMed:9305888};
DE              EC=3.2.1.183 {ECO:0000269|PubMed:10334995, ECO:0000269|PubMed:10497249, ECO:0000269|PubMed:9305887, ECO:0000269|PubMed:9305888};
DE     AltName: Full=UDP-GlcNAc-2-epimerase;
DE     AltName: Full=Uridine diphosphate-N-acetylglucosamine-2-epimerase;
DE     AltName: Full=rEpi;
DE   Includes:
DE     RecName: Full=N-acetylmannosamine kinase {ECO:0000305|PubMed:9305888};
DE              EC=2.7.1.60 {ECO:0000269|PubMed:10497249, ECO:0000269|PubMed:9305887, ECO:0000269|PubMed:9305888};
DE     AltName: Full=ManAc kinase;
GN   Name=Gne {ECO:0000312|RGD:69239}; Synonyms=Glcne;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 153-162; 269-277; 309-321;
RP   434-441 AND 491-500, FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=9305888; DOI=10.1074/jbc.272.39.24319;
RA   Staesche R., Hinderlich S., Weise C., Effertz K., Lucka L., Moormann P.,
RA   Reutter W.;
RT   "A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic
RT   acid biosynthesis of rat liver. Molecular cloning and functional expression
RT   of UDP-N-acetyl-glucosamine 2-epimerase/N-acetylmannosamine kinase.";
RL   J. Biol. Chem. 272:24319-24324(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, PATHWAY, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=9305887; DOI=10.1074/jbc.272.39.24313;
RA   Hinderlich S., Staesche R., Zeitler R., Reutter W.;
RT   "A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic
RT   acid biosynthesis of rat liver. Purification and characterization of UDP-N-
RT   acetylglucosamine 2-epimerase/N-acetylmannosamine kinase.";
RL   J. Biol. Chem. 272:24313-24318(1997).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=10103025; DOI=10.1046/j.1432-1327.1999.00253.x;
RA   Horstkorte R., Noehring S., Wiechens N., Schwarzkopf M., Danker K.,
RA   Reutter W., Lucka L.;
RT   "Tissue expression and amino acid sequence of murine UDP-N-
RT   acetylglucosamine-2-epimerase/N-acetylmannosamine kinase.";
RL   Eur. J. Biochem. 260:923-927(1999).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, REGION, AND MUTAGENESIS OF HIS-49;
RP   HIS-110; HIS-132; HIS-155; HIS-157; ASP-413 AND ARG-420.
RX   PubMed=10497249; DOI=10.1074/jbc.274.40.28771;
RA   Effertz K., Hinderlich S., Reutter W.;
RT   "Selective loss of either the epimerase or kinase activity of UDP-N-
RT   acetylglucosamine 2-epimerase/N-acetylmannosamine kinase due to site-
RT   directed mutagenesis based on sequence alignments.";
RL   J. Biol. Chem. 274:28771-28778(1999).
RN   [6]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=10334995; DOI=10.1126/science.284.5418.1372;
RA   Keppler O.T., Hinderlich S., Langner J., Schwartz-Albiez R., Reutter W.,
RA   Pawlita M.;
RT   "UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation.";
RL   Science 284:1372-1376(1999).
CC   -!- FUNCTION: Bifunctional enzyme that possesses both UDP-N-
CC       acetylglucosamine 2-epimerase and N-acetylmannosamine kinase
CC       activities, and serves as the initiator of the biosynthetic pathway
CC       leading to the production of N-acetylneuraminic acid (NeuAc), a
CC       critical precursor in the synthesis of sialic acids. By catalyzing this
CC       pivotal and rate-limiting step in sialic acid biosynthesis, this enzyme
CC       assumes a pivotal role in governing the regulation of cell surface
CC       sialylation (PubMed:10497249, PubMed:9305887, PubMed:9305888). Sialic
CC       acids represent a category of negatively charged sugars that reside on
CC       the surface of cells as terminal components of glycoconjugates and
CC       mediate important functions in various cellular processes, including
CC       cell adhesion, signal transduction, and cellular recognition
CC       (PubMed:10334995). {ECO:0000269|PubMed:10334995,
CC       ECO:0000269|PubMed:10497249, ECO:0000269|PubMed:9305887,
CC       ECO:0000269|PubMed:9305888}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + UDP-N-acetyl-alpha-D-glucosamine = aldehydo-N-acetyl-D-
CC         mannosamine + H(+) + UDP; Xref=Rhea:RHEA:30683, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17122, ChEBI:CHEBI:57705,
CC         ChEBI:CHEBI:58223; EC=3.2.1.183;
CC         Evidence={ECO:0000269|PubMed:10334995, ECO:0000269|PubMed:10497249,
CC         ECO:0000269|PubMed:9305887, ECO:0000269|PubMed:9305888};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:30684;
CC         Evidence={ECO:0000269|PubMed:10497249};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-acyl-D-mannosamine + ATP = ADP + an N-acyl-D-mannosamine
CC         6-phosphate + H(+); Xref=Rhea:RHEA:23832, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16062, ChEBI:CHEBI:30616, ChEBI:CHEBI:57666,
CC         ChEBI:CHEBI:456216; EC=2.7.1.60;
CC         Evidence={ECO:0000269|PubMed:10497249, ECO:0000269|PubMed:9305887,
CC         ECO:0000269|PubMed:9305888};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23833;
CC         Evidence={ECO:0000269|PubMed:10497249};
CC   -!- ACTIVITY REGULATION: The UDP-N-acetylglucosamine 2-epimerase activity,
CC       in contrast to the N-acetylmannosamine kinase activity, exhibits
CC       allosteric regulation by cytidine monophosphate-N-acetylneuraminic acid
CC       (CMP-Neu5Ac), the end product of neuraminic acid biosynthesis
CC       (PubMed:9305887). Moreover, the activity is contingent upon the
CC       oligomeric state of the enzyme. The monomeric form is inactive, while
CC       the dimeric form selectively catalyzes the phosphorylation of N-
CC       acetylmannosamine. The hexameric form, on the other hand, demonstrates
CC       full proficiency in both enzyme activities (PubMed:9305887).
CC       Furthermore, the UDP-N-acetylglucosamine 2-epimerase activity is
CC       increased by PKC-mediated phosphorylation (By similarity).
CC       {ECO:0000250|UniProtKB:Q91WG8, ECO:0000269|PubMed:9305887}.
CC   -!- PATHWAY: Amino-sugar metabolism; N-acetylneuraminate biosynthesis.
CC       {ECO:0000269|PubMed:10497249, ECO:0000269|PubMed:9305887,
CC       ECO:0000269|PubMed:9305888}.
CC   -!- SUBUNIT: Homodimer. Homotetramer. Homohexamer (PubMed:9305887). The
CC       hexameric form exhibits both enzyme activities, whereas the dimeric
CC       form only catalyzes the phosphorylation of N-acyl-D-mannosamine
CC       (PubMed:9305887). {ECO:0000269|PubMed:9305887}.
CC   -!- INTERACTION:
CC       O35826; Q05516: ZBTB16; Xeno; NbExp=2; IntAct=EBI-7109445, EBI-711925;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:9305887,
CC       ECO:0000269|PubMed:9305888}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highest expression is observed in
CC       liver. {ECO:0000269|PubMed:10103025, ECO:0000269|PubMed:9305888}.
CC   -!- PTM: Phosphorylated. Phosphorylation by PKC activates the UDP-N-
CC       acetylglucosamine 2-epimerase activity. {ECO:0000250|UniProtKB:Q91WG8}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the UDP-N-
CC       acetylglucosamine 2-epimerase family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the ROK (NagC/XylR)
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y07744; CAA69024.1; -; mRNA.
DR   EMBL; BC062011; AAH62011.1; -; mRNA.
DR   RefSeq; NP_446217.1; NM_053765.2.
DR   RefSeq; XP_006238070.1; XM_006238008.1.
DR   RefSeq; XP_006238071.1; XM_006238009.3.
DR   AlphaFoldDB; O35826; -.
DR   SMR; O35826; -.
DR   BioGRID; 250408; 6.
DR   IntAct; O35826; 5.
DR   MINT; O35826; -.
DR   STRING; 10116.ENSRNOP00000074334; -.
DR   GlyGen; O35826; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O35826; -.
DR   PhosphoSitePlus; O35826; -.
DR   jPOST; O35826; -.
DR   PaxDb; 10116-ENSRNOP00000019532; -.
DR   Ensembl; ENSRNOT00000019532.6; ENSRNOP00000019532.3; ENSRNOG00000014365.8.
DR   Ensembl; ENSRNOT00055035487; ENSRNOP00055028775; ENSRNOG00055020776.
DR   Ensembl; ENSRNOT00060007528; ENSRNOP00060005686; ENSRNOG00060004446.
DR   Ensembl; ENSRNOT00065016357; ENSRNOP00065012414; ENSRNOG00065010137.
DR   GeneID; 114711; -.
DR   KEGG; rno:114711; -.
DR   UCSC; RGD:69239; rat.
DR   AGR; RGD:69239; -.
DR   CTD; 10020; -.
DR   RGD; 69239; Gne.
DR   eggNOG; ENOG502QUGI; Eukaryota.
DR   GeneTree; ENSGT00390000017246; -.
DR   HOGENOM; CLU_023411_0_0_1; -.
DR   InParanoid; O35826; -.
DR   OrthoDB; 5489121at2759; -.
DR   PhylomeDB; O35826; -.
DR   BioCyc; MetaCyc:MONOMER-14506; -.
DR   BRENDA; 5.1.3.14; 5301.
DR   Reactome; R-RNO-4085001; Sialic acid metabolism.
DR   SABIO-RK; O35826; -.
DR   UniPathway; UPA00630; -.
DR   PRO; PR:O35826; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000014365; Expressed in colon and 20 other cell types or tissues.
DR   ExpressionAtlas; O35826; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0009384; F:N-acylmannosamine kinase activity; IDA:UniProtKB.
DR   GO; GO:0008761; F:UDP-N-acetylglucosamine 2-epimerase activity; IDA:UniProtKB.
DR   GO; GO:0006045; P:N-acetylglucosamine biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0046380; P:N-acetylneuraminate biosynthetic process; ISO:RGD.
DR   GO; GO:0006047; P:UDP-N-acetylglucosamine metabolic process; IEA:InterPro.
DR   CDD; cd03786; GTB_UDP-GlcNAc_2-Epimerase; 1.
DR   CDD; cd00012; NBD_sugar-kinase_HSP70_actin; 1.
DR   Gene3D; 3.30.420.40; -; 2.
DR   Gene3D; 3.40.50.2000; Glycogen Phosphorylase B; 2.
DR   InterPro; IPR043129; ATPase_NBD.
DR   InterPro; IPR000600; ROK.
DR   InterPro; IPR020004; UDP-GlcNAc_Epase.
DR   InterPro; IPR003331; UDP_GlcNAc_Epimerase_2_dom.
DR   NCBIfam; TIGR03568; NeuC_NnaA; 1.
DR   PANTHER; PTHR18964:SF149; BIFUNCTIONAL UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE_N-ACETYLMANNOSAMINE KINASE; 1.
DR   PANTHER; PTHR18964; ROK (REPRESSOR, ORF, KINASE) FAMILY; 1.
DR   Pfam; PF02350; Epimerase_2; 1.
DR   Pfam; PF00480; ROK; 1.
DR   PRINTS; PR00475; HEXOKINASE.
DR   SUPFAM; SSF53067; Actin-like ATPase domain; 1.
DR   SUPFAM; SSF53756; UDP-Glycosyltransferase/glycogen phosphorylase; 1.
PE   1: Evidence at protein level;
KW   Allosteric enzyme; ATP-binding; Cytoplasm; Direct protein sequencing;
KW   Hydrolase; Kinase; Magnesium; Metal-binding; Multifunctional enzyme;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Transferase; Zinc.
FT   CHAIN           1..722
FT                   /note="Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-
FT                   acetylmannosamine kinase"
FT                   /id="PRO_0000095718"
FT   REGION          1..?
FT                   /note="UDP-N-acetylglucosamine 2-epimerase"
FT                   /evidence="ECO:0000269|PubMed:10497249"
FT   REGION          406..722
FT                   /note="N-acetylmannosamine kinase"
FT                   /evidence="ECO:0000269|PubMed:10497249"
FT   ACT_SITE        517
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         19
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         23
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         113
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         220
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         253
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         259
FT                   /ligand="CMP-N-acetyl-beta-neuraminate"
FT                   /ligand_id="ChEBI:CHEBI:57812"
FT                   /ligand_note="allosteric inhibitor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         271
FT                   /ligand="CMP-N-acetyl-beta-neuraminate"
FT                   /ligand_id="ChEBI:CHEBI:57812"
FT                   /ligand_note="allosteric inhibitor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         280
FT                   /ligand="CMP-N-acetyl-beta-neuraminate"
FT                   /ligand_id="ChEBI:CHEBI:57812"
FT                   /ligand_note="allosteric inhibitor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         281
FT                   /ligand="CMP-N-acetyl-beta-neuraminate"
FT                   /ligand_id="ChEBI:CHEBI:57812"
FT                   /ligand_note="allosteric inhibitor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         282
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         301
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         302
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         307
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         321
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         413
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         416
FT                   /ligand="an N-acyl-D-mannosamine 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57666"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         417
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         418
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         420
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         476
FT                   /ligand="an N-acyl-D-mannosamine"
FT                   /ligand_id="ChEBI:CHEBI:16062"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         476
FT                   /ligand="an N-acyl-D-mannosamine 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57666"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         477
FT                   /ligand="an N-acyl-D-mannosamine"
FT                   /ligand_id="ChEBI:CHEBI:16062"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         477
FT                   /ligand="an N-acyl-D-mannosamine 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57666"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         489
FT                   /ligand="an N-acyl-D-mannosamine"
FT                   /ligand_id="ChEBI:CHEBI:16062"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         489
FT                   /ligand="an N-acyl-D-mannosamine 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57666"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         516
FT                   /ligand="an N-acyl-D-mannosamine"
FT                   /ligand_id="ChEBI:CHEBI:16062"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         516
FT                   /ligand="an N-acyl-D-mannosamine 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57666"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         517
FT                   /ligand="an N-acyl-D-mannosamine"
FT                   /ligand_id="ChEBI:CHEBI:16062"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         517
FT                   /ligand="an N-acyl-D-mannosamine 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57666"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         545
FT                   /ligand="an N-acyl-D-mannosamine 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57666"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         566
FT                   /ligand="an N-acyl-D-mannosamine"
FT                   /ligand_id="ChEBI:CHEBI:16062"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         569
FT                   /ligand="an N-acyl-D-mannosamine"
FT                   /ligand_id="ChEBI:CHEBI:16062"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         569
FT                   /ligand="an N-acyl-D-mannosamine 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57666"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         569
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         579
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         581
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         586
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         588
FT                   /ligand="an N-acyl-D-mannosamine"
FT                   /ligand_id="ChEBI:CHEBI:16062"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   BINDING         588
FT                   /ligand="an N-acyl-D-mannosamine 6-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57666"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y223"
FT   MUTAGEN         49
FT                   /note="H->A: Loss UDP-N-acetylglucosamine 2-epimerase
FT                   activity. No effect on N-acylmannosamine kinase activity.
FT                   Does not interfere with enzyme oligomerization."
FT                   /evidence="ECO:0000269|PubMed:10497249"
FT   MUTAGEN         110
FT                   /note="H->A: Loss UDP-N-acetylglucosamine 2-epimerase
FT                   activity. No effect on N-acylmannosamine kinase activity.
FT                   Partial reduction of the dimerization process."
FT                   /evidence="ECO:0000269|PubMed:10497249"
FT   MUTAGEN         132
FT                   /note="H->A: Loss UDP-N-acetylglucosamine 2-epimerase
FT                   activity. No effect on N-acylmannosamine kinase activity.
FT                   Partial reduction of the dimerization process."
FT                   /evidence="ECO:0000269|PubMed:10497249"
FT   MUTAGEN         155
FT                   /note="H->A: Loss UDP-N-acetylglucosamine 2-epimerase
FT                   activity. No effect on N-acylmannosamine kinase activity.
FT                   Strong reduction of the dimerization process."
FT                   /evidence="ECO:0000269|PubMed:10497249"
FT   MUTAGEN         157
FT                   /note="H->A: Loss UDP-N-acetylglucosamine 2-epimerase
FT                   activity. No effect on N-acylmannosamine kinase activity.
FT                   Strong reduction of the dimerization process."
FT                   /evidence="ECO:0000269|PubMed:10497249"
FT   MUTAGEN         413
FT                   /note="D->K,N: No effect on UDP-N-acetylglucosamine 2-
FT                   epimerase activity. Does not affect feedback inhibition by
FT                   CMP-Neu5Ac. Loss of N-acylmannosamine kinase activity. Does
FT                   not interfere with oligomerization."
FT                   /evidence="ECO:0000269|PubMed:10497249"
FT   MUTAGEN         420
FT                   /note="R->M: No effect on UDP-N-acetylglucosamine 2-
FT                   epimerase activity. Does not affect feedback inhibition by
FT                   CMP-Neu5Ac. Loss of N-acylmannosamine kinase activity. Does
FT                   not interfere with oligomerization."
FT                   /evidence="ECO:0000269|PubMed:10497249"
SQ   SEQUENCE   722 AA;  79227 MW;  0DFDC84E833C7984 CRC64;
     MEKNGNNRKL RVCVATCNRA DYSKLAPIMF GIKTEPAFFE LDVVVLGSHL IDDYGNTYRM
     IEQDDFDINT RLHTIVRGED EAAMVESVGL ALVKLPDVLN RLKPDIMIVH GDRFDALALA
     TSAALMNIRI LHIEGGEVSG TIDDSIRHAI TKLAHYHVCC TRSAEQHLIS MCEDHDRILL
     AGCPSYDKLL SAKNKDYMSI IRMWLGDDVK CKDYIVALQH PVTTDIKHSI KMFELTLDAL
     ISFNKRTLVL FPNIDAGSKE MVRVMRKKGI EHHPNFRAVK HVPFDQFIQL VAHAGCMIGN
     SSCGVREVGA FGTPVINLGT RQIGRETGEN VLHVRDADTQ DKILQALHLQ FGKQYPCSKI
     YGDGNAVPRI LKFLKSIDLQ EPLQKKFCFP PVKENISQDI DHILETLSAL AVDLGGTNLR
     VAIVSMKGEI VKKYTQFNPK TYEERISLIL QMCVEAAAEA VKLNCRILGV GISTGGRVNP
     QEGVVLHSTK LIQEWNSVDL RTPLSDTLHL PVWVDNDGNC AAMAERKFGQ GKGQENFVTL
     ITGTGIGGGI IHQHELIHGS SFCAAELGHL VVSLDGPDCS CGSHGCIEAY ASGMALQREA
     KKLHDEDLLL VEGMSVPKDE AVGALHLIQA AKLGNVKAQS ILRTAGTALG LGVVNILHTM
     NPSLVILSGV LASHYIHIVR DVIRQQALSS VQDVDVVVSD LVDPALLGAA SMVLDYTTRR
     IH
//
